1887

Chapter 26 : Progressive Multifocal Leukoencephalopathy in the Era of HAART

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Progressive Multifocal Leukoencephalopathy in the Era of HAART, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap26-1.gif /docserver/preview/fulltext/10.1128/9781555815691/9781555813697_Chap26-2.gif

Abstract:

Progressive multifocal leukoencephalopathy (PML) is an important viral infection of the central nervous system that has attracted increasing attention in recent years because of the surge in incidence accompanying the epidemic of the human immunodeficiency virus (HIV). An interesting problem raising concern among neuro-AIDS experts has been the development of an increasing number of serious, undiagnosed white matter conditions in the setting of highly active antiretroviral therapy (HAART). Clinical presentations of PML are also helpful in suggesting the diagnosis. While the disease is often pathologically multifocal, it is most commonly clinically characteristic of a progressive focal disease. Analysis of the cerebrospinal fluid (CSF) has been complementary to examination and magnetic resonance (MR) scanning and has improved the sensitivity and specificity to the point that in most cases, even for research purposes, a brain biopsy does not appear to be necessary. Numerous case reports of cytosine arabinoside (cytarabine) treatment associated with disease arrest were included in the literature through the years. PML remains an important challenge for clinicians and researchers. Increasing ability to detect and tract the activity of this ubiquitous virus will enhance our understanding of its pathobiology.

Citation: Clifford D. 2009. Progressive Multifocal Leukoencephalopathy in the Era of HAART, p 375-382. In Goodkin K, Shapshak P, Verma A (ed), The Spectrum of Neuro-AIDS Disorders. ASM Press, Washington, DC. doi: 10.1128/9781555815691.ch26

Key Concept Ranking

Highly Active Antiretroviral Therapy
0.45348954
0.45348954
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

References

/content/book/10.1128/9781555815691.ch26
1. Aksamit, A. J. 1993. Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy. Mayo Clin. Proc. 68:899910.
2. Aksamit, A. J. 2001. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J. Neurovirol. 7:386390.
3. Aksamit, A. J.,, J. L. Sever, and, E. O. Major. 1986. Progressive multifocal leukoencephalopathy: JC virus detection by in situ hybridization compared with immunohistochemistry. Neurology 36:499504.
4. Angelini, L.,, M. C. Pietrogrande,, M. R. Delle Piane,, F. Zibordi,, P. Cinque,, C. Maccagnano, and, L. Vago. 2001. Progressive multifocal leukoencephalopathy in a child with hyperimmunoglobulin E recurrent infection syndrome and review of the literature. Neuropediatrics 32:250255.
5. Antinori, A.,, A. Ammassari,, P. Cinque,, L. Toma,, A. Govoni,, F. Soldani,, M. L. Giancola,, S. Grisetti,, C. Pierotti,, C. Fausti,, M. G. Finazzi,, T. Bini,, B. Del Grosso,, L. Cristiano,, P. Corsi,, G. Fasulo,, M. Mena,, G. Guaraldi,, M. I. Arcidiacono,, L. Monno,, B. Gigli,, G. C. Fibbia,, M. Gentile,, A. Mastroianni,, F. Speranza,, A. d’Arminio Monforte,, G. Rezza, and, G. Ippolito. 2001. Shift of prevalence and selected characteristics in HIV-1-related neurologic disorders in HAART era: data from Italian Register Investigative Neuro AIDS (IRINA), p. 45. In 8th Conference on Retroviruses and Opportunistic Infections. CROI, Alexandria, VA.
6. Antinori, A.,, A. Ammassari,, A. De Luca,, A. Cingolani,, R. Murri,, G. Scoppettuolo,, M. Fortini,, T. Tartaglione,, L. M. Larocca,, G. Zannoni,, P. Cattani,, R. Grillo,, R. Roselli,, M. Iacoangeli,, M. Scerrati, and, L. Ortona. 1997. Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology 48:687694.
7. Astrom, K. E.,, E. L. Mancall, and, E. P. Richardson, Jr. 1958. Progressive multifocal leukoencephalopathy, a hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin’s disease. Brain 81:93111.
8. Bauer, W. R.,, A. P. Truel, and, K. P. Johnson. 1973. Progressive multifocal leukoencephalopathy and cytarabine. JAMA 226:174176.
9. Berenguer, J.,, P. Miralles,, J. Arrizabalaga,, E. Ribera,, F. Dronda,, J. Baraia,, P. Domingo,, M. Marquez,, F. J. Rodriguez-Arrondo,, F. Laguna,, R. Rubio,, J. López-Aldeguer,, V. De Meguel,and Gesida 11/99 Study Group. 2001. Clinical course and prognostic factors of AIDS-associated progressive multifocal leukoencephalopathy (PML) in patients treated with HAART, p. 45. In 8th Conference on Retroviruses and Opportunistic Infection. CROI, Alexandria, VA.
10. Berger, J. R.,, R. M. Levy,, D. Flomenhoft, and, M. Dobbs. 1998a. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann. Neurol. 44:341349.
11. Berger, J. R.,, and L. Mucke. 1988. Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 38:10601065.
12. Berger, J. R.,, L. Pall,, D. Lanska, and, M. Whiteman. 1998b. Progressive multifocal leukoencephalopathy in patients with HIV infection. J. Neurovirol. 4:5968.
13. Blick, G.,, M. Whiteside,, P. Griegor,, U. Hopkins,, T. Garton, and, L. LaGravinese. 1998. Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside. Clin. Infect. Dis. 26:191192.
14. Chang, L.,, T. Ernst,, C. Tornatore,, H. Aronow,, R. Melchor,, I. Walot,, E. Singer, and, M. Cornford. 1997. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton magnetic resonance spectroscopy. Neurology 48:836845.
15. Cinque, P.,, S. Casari, and, D. Bertelli. 1998. Progressive multifocal leukoencephalopathy, HIV and highly active antiretroviral therapy. N. Engl. J. Med. 339:848849.
16. Cinque, P.,, C. Pierotti,, M. G. Vigano,, A. Bestetti,, C. Fausti,, D. Bertelli, and, A. Lazzarin. 2001. The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J. Neurovirol. 7:358363.
17. Clifford, D. B.,and Neurological AIDS Research Consortium Study Team. 1998. Impact on highly active antiretroviral therapy on survival from progressive multifocal leukoencephalopathy in human immunodeficiency virus infection. Neurology 50: A249.
18. Clifford, D. B.,, C. Yiannoutsos,, M. Glicksman,, D. M. Simpson,, E. J. Singer,, P. J. Piliero,, C. M. Marra,, G. S. Francis,, J. C. McArthur,, K. L. Tyler,, A. C. Tselis, and, N. E. Hyslop. 1999. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623625.
19. De Luca, A.,, A. Cingolani,, A. Linzalone,, A. Ammassari,, R. Murri,, M. L. Giancola,, G. Maiuro, and, A. Antinori. 1996. Improved detection of JC virus DNA in cerebrospinal fluid for diagnosis of AIDS-related progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 34:13431346.
20. De Luca, A.,, M. L. Giancola,, A. Ammassari,, S. Grisetti,, A. Cingolani,, M. G. Paglia,, A. Govoni,, R. Murri,, L. Testa,, A. d’Arminio Monforte, and, A. Antinori. 2000. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 14:15.
21. De Luca, A.,, M. L. Giancola,, A. Cingolani,, A. Ammassari,, L. Gillini,, R. Murri, and, A. Antinori. 1999. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy. Clin. Infect. Dis. 28:624628.
22. De Viedma, D. G.,, R. Alonso,, P. Miralles,, J. Berenguer,, M. Rodriguez-Créixems, and, E. Bouza. 1999. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J. Clin. Microbiol. 37:724728.
23. Du Pasquier, R. A.,, K. W. Clark,, P. S. Smith,, J. T. Joseph,, J. M. Mazullo,, U. De Girolami,, N. L. Letvin, and, I. J. Koralnik. 2001. JCV-specific cellular immune response correlates with a favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy. J. Neurovirol. 7:318322.
24. Dupont, B.,, D. Fish,, D. McGuire,, W. Royal,, E. Singer,, K. Goodkin,, D. Graden,, H. Martino,, S. Hearn,, G. Ross, and, R. Beckman. 2001. 21-day continuous infusion of Topotecan in AIDS-associated progressive multifocal leukoencephalopathy (PML), p. 223. In 8th Conference on Retroviruses and Opportunistic Infections. CROI, Alexandria, VA.
25. Dworkin, M. S.,, P. T. Wan,, D. L. Hanson,, J. L. Jones,and Adult & Adolescent Spectrum of HIV Disease Project. 1999. Progressive multifocal leukoencephalopathy: improved survival of human immunodeficiency virus-infected patients in the protease inhibitor era. J. Infect. Dis. 180:621625.
26. Elphick, G. F.,, W. Querbes,, J. A. Jordan,, G. V. Gee,, S. Eash,, K. Manley,, A. Dugan,, M. Stanifer,, A. Bhatnagar,, W. Kroeze,, B. L. Roth, and, W. J. Atwood. 2004. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:13801383.
27. Enting, R. H.,, and P. Portegies. 2000. Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy. J. Neurol. 247:134138.
28. Garcia, D.,, V. I. M. Diaz,, P. Miralles,, J. Berenguer,, M. Marin,, L. Munoz, and, E. Bouza. 2002. JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fluid, patient survival, and the volume of neurological lesions. Clin. Infect. Dis. 34:15681575.
29. Gasnault, J.,, M. Kahraman,, M. G. de Goër,, J. F. Delfraissy, and, Y. Taoufik. 2002. Analysis of anti-JC virus CD4+ T-cell response in healthy subjects and in HIV+ patients with or without progressive multifocal leukoencephalopathy, p. 317. In 9th Conference on Retroviruses and Opportunistic Infections. CROI, Alexandria, VA.
30. Gasnault, J.,, P. Kousignian,, M. Kahraman,, J. Rahoiljaon,, S. Matheron,, J. F. Delfraissy, and, Y. Taoufik. 2001. Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J. Neurovirol. 7:375381.
31. Gasnault, J.,, Y. Taoufik,, C. Goujard,, P. Kousignian,, K. Abbed,, F. Boué,, E. Dussaix, and, J. F. Delfraissy. 1999. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy. J. Neurovirol. 5:421429.
32. Geschwind, M. D.,, R. I. Skolasky,, W. S. Royal, and, J. C. McArthur. 2001. The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J. Neurovirol. 7:353357.
33. Gibson, P. E.,, W. A. Knowles,, J. F. Hand, and, D. W. G. Brown. 1993. Detection of JC virus DNA in the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J. Med. Virol. 39:278281.
34. Giudici, B.,, B. Vaz,, S. Bossolasco,, S. Casari,, A. M. Brambilla,, W. Lüke,, A. Lazzarin,, T. Weber, and, P. Cinque. 2000. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin. Infect. Dis. 30:9599.
35. Hall, C. D.,, U. Dafni,, D. Simpson,, D. B. Clifford,, P. E. Wetherill,, B. Cohen,, J. C. McArthur,, H. Hollander,, C. Yiannoutsos,, E. Major,, L. Millar,, J. Timpone,and AIDS Clinical Trials Group 243 Team. 1998. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N. Engl. J. Med. 338:13451351.
36. Hammarin, A. L.,, G. Bogdanovic,, V. Svedhem,, R. Pirskanen,, L. Morfeldt, and, M. Grandien. 1996. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 34:29292932.
37. Hansman-Whiteman, M. L.,, M. J. Donovan Post,, J. R. Berger,, L. G. Tate,, M. D. Bell, and, L. P. Limonte. 1993. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 187:233240.
38. Hou, J.,, and E. O. Major. 1998. The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J. Neurovirol. 4:451456.
39. Howatson, A. F.,, M. Nagai, and, G. M. ZuRhein. 1965. Polyoma-like virions in human demyelinating brain disease. Can. Med. Assoc. J. 93:379386.
40. Huang, S. S.,, R. L. Skolasky,, G. J. Dal Pan,, W. Royal III, and, J. C. McArthur. 1998. Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J. Neurovirol. 4:324332.
41. Inui, K.,, H. Miyagawa,, J. Sashihara,, H. Miyoshi,, K. Tanaka-Taya,, T. Nishigaki,, S. Teraoka,, T. Mano,, J. Ono, and, S. Okada. 1999. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Brain Dev. 21:416419.
42. Iranzo, A.,, A. Moreno,, J. Pujol,, J. Martí-Fàbregas,, P. Domingo,, J. Molet,, J. Ris, and, J. Cadafalch. 1999. Proton magnetic resonance spectroscopy pattern of progressive multifocal leukoencephalopathy in AIDS. J. Neurol. Neurosurg. Psychiatry 66:520523.
43. Jensen, P. N.,, and E. O. Major. 2001. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J. Neurovirol. 7:280287.
44. Jochum, W.,, T. Weber,, S. Frye,, G. Hunsmann,, W. Lüke, and, A. Aguzzi. 1997. Detection of JC virus by anti-VP1 immunohistochemistry in brains with progressive multifocal leukoencephalopathy. Acta Neuropathol. 94:226231.
45. Katz, D. A.,, J. R. Berger,, B. Hamilton,, E. O. Major, and, J. Donovan Post. 1994. Progressive multifocal leukoencephalopathy complicating Wiskott-Aldrich syndrome. Arch. Neurol. 51:422426.
46. Katz-Brull, R.,, R. E. Lenkinski,, R. A. Du Pasquier, and, I. J. Koralnik. 2004. Elevation of myoinositol is associated with disease containment in progressive multifocal leukoencephalopathy. Neurology 63:897900.
47. Kinoshita, M.,, K. Iwana,, H. Shinoura,, S. Aotsuka, and, M. Sumiya. 1998. Progressive multifocal leukoencephalopathy resembling central nervous system systemic lupus erythematosus. Clin. Exp. Rheumatol. 16:313315.
48. Kleinschmidt-DeMasters, B. K.,, and K. L. Tyler. 2005. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N. Engl. J. Med. 353:369374.
49. Knowles, W. A.,, P. Pipkin,, N. Andrews,, A. Vyse,, P. Minor,, W. G. Brown, and, E. Miller. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71:115123.
50. Koralnik, I. J. 2002. Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy. J. Neurovirol. 8:5965.
51. Koralnik, I. J.,, R. A. Du Pasquier, and, N. L. Letvin. 2001. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J. Virol. 75:34833487.
52. Koralnik, I. J.,, J. E. Schmitz,, M. A. Lifton,, M. A. Forman, and, N. L. Letvin. 1999. Detection of JC virus DNA in peripheral blood cell subpopulations of HIV-1-infected individuals. J. Neurovirol. 5:430435.
53. Kotecha, N.,, M. J. George,, T. W. Smith,, F. Corvi, and, N. S. Litofsky. 1998. Enhancing progressive multifocal leukoencephalopathy: an indicator of improved immune status. Am. J. Med. 105:541543.
54. Langer-Gould, A.,, S. W. Atlas,, A. W. Bollen, and, D. Pelletier. 2005. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N. Engl. J. Med. 353:375381.
55. Langford, T. D.,, S. L. Letendre,, T. D. Marcotte,, R. J. Ellis,, J. A. McCutchan,, I. Grant,, M. E. Mallory,, L. A. Hansen,, S. Archibald,, T. Jernigan,, E. Masliah,and HNRC Group. 2002. Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16:10191029.
56. Levy, R. M.,, E. Major,, M. J. Ali,, B. Cohen, and, D. Groothius. 2001. Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML). J. Neurovirol. 7:382385.
57. Lima, M. A.,, A. Marzocchetti,, P. Autissier,, T. Tompkins,, Y. Chen,, J. Gordon,, D. B. Clifford,, R. T. Gandhi,, N. Venna,, J. R. Berger, and, I. J. Koralnik. 2007. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J. Virol. 81:33613368.
58. Major, E. O.,, K. Amemiya,, C. S. Tornatore,, S. A. Houff, and, J. R. Berger. 1992. Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 5:4973.
59. Marra, C. M.,, N. Rajicic,, D. E. Barker,, B. Cohen,, D. Clifford,and ACTG 363 Team. 2001. Prospective pilot study of Cidofovir for HIV-associated progressive multifocal leukoencephalopathy (PML), p. 233. In 8th Conference on Retroviruses and Opportunistic Infections. CROI, Alexandria, VA.
60. Marra, C. M.,, N. Rajicic,, D. E. Barker,, B. A. Cohen,, D. Clifford,, M. J. D. Post,, A. Ruiz,, B. C. Bowen,, M. L. Huang,, J. Queen-Baker,, J. Andersen,, S. Kelly,, S. Shriver,and ACTG 363 Team. 2002. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16:17.
61. Marriott, P. J.,, M. D. O’Brien,, I. C. K. MacKensie, and, I. Janota. 1975. Progressive multifocal leukoencephalopathy: remission with cytarabine. J. Neurol. Neurosurg. Psychiatry 38:205209.
62. Marzocchetti, A.,, S. Di Giambenedetto,, A. Cingolani,, A. Ammassari,, R. Cauda, and, A. De Luca. 2005. Reduced rate of diagnostic positive detection of JC virus DNA in cerebrospinal fluid in cases of suspected progressive multifocal leukoencephalopathy in the era of potent antiretroviral therapy. J. Clin. Microbiol. 43:41754177.
63. McGuire, D.,, S. Barhite,, H. Hollander, and, M. Miles. 1995. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy. Ann. Neurol. 37:395399.
64. Miralles, P.,, J. Berenguer,, D. García de Viedma,, B. Padilla,, J. Cosin,, J. C. Lopez-Bernaldo de Quirós,, L. Muñoz,, S. Moreno, and, E. Bouza. 1998. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12:24672472.
65. Miralles, P.,, J. Berenguer,, C. Lacruz,, J. Cosin,, J. C. Lopez,, B. Padilla,, L. Muñoz, and, D. García de Viedma. 2001. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15:19001902.
66. Morgenstern, L. B.,, and C. A. Pardo. 1995. Progressive multifocal leukoencephalopathy complicating treatment for Wegener’s granulomatosis. J. Rheumatol. 22:15931595.
67. Mori, M.,, N. Aoki,, H. Shimada,, M. Tajima, and, K. Kato. 1992. Detection of JC virus in the brains of aged patients without progressive multifocal leukoencephalopathy by the polymerase chain reaction and Southern hybridization analysis. Neurosci. Lett. 141:151155.
68. Padgett, B. L.,, G. M. ZuRhein,, D. L. Walker, and, R. J. Eckroade. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet i:12571260.
69. Perrons, C. J.,, J. D. Fox,, S. B. Lucas,, N. S. Brink,, R. S. Tedder, and, R. F. Miller. 1996. Detection of polyomaviral DNA in clinical samples from immunocompromised patients: correlation with clinical disease. J. Infect. 32:205209.
70. Pfister, L. A.,, N. L. Letvin, and, I. J. Koralnik. 2001. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J. Virol. 75:56725676.
71. Portilla, J.,, V. Boix,, F. Román,, S. Reus, and, E. Merino. 2000. Progressive multifocal leukoencephalopathy treated with Cidofovir in HIV-infected patients receiving highly active antiretroviral therapy. J. Infect. 41:182183.
72. Power, C.,, A. Nath,, F. Y. Aoki, and, M. Del Bigio. 1997. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N. Engl. J. Med. 336:661662.
73. Przepiorka, D.,, K. A. Jaeckle,, R. R. Birdwell,, G. N. Fuller,, A. J. Kumar,, Y. O. Huh, and, I. McCutcheon. 1997. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant. 20:983987.
74. Rankin, E.,, and F. Scaravilli. 1995. Progressive multifocal leukoencephalopathy in a patient with rheumatoid arthritis and polymyositis. J. Rheumatol. 22:777779.
75. Razonable, R. R.,, A. J. Aksamit,, A. J. Wright, and, J. W. Wilson. 2001. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin. Proc. 76:11711175.
76. Re, D.,, S. Bamborschke,, W. Feiden,, R. Schröder,, R. Lehrke,, V. Diehl, and, H. Tesch. 1999. Case report: progressive multifocal leukoencephalopathy after autologous bone marrow transplantation and alpha-interferon immunotherapy. Bone Marrow Transplant. 23:295298.
77. Richardson-Burns, S. M.,, B. K. Kleinschmidt-DeMasters,, R. L. DeBiasi, and, K. L. Tyler. 2002. Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch. Neurol. 59:19301936.
78. Scotton, P. G.,, A. Vaglia,, A. Carniato, and, G. C. Marchiori. 1998. Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency. Clin. Infect. Dis. 26:215216.
79. Snyder, M. D.,, G. A. Storch, and, D. B. Clifford. 2005. Atypical PML leading to a diagnosis of common variable immunodeficiency. Neurology 64: 1661.
80. Steiger, M. J.,, G. Tarnesby,, S. Gabe,, J. McLaughlin, and, A. H. V. Schapira. 1993. Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann. Neurol. 33:407411.
81. Stolt, A.,, K. Sasnauskas,, P. Koskela,, M. Lehtinen, and, J. Dillner. 2003. Seroepidemiology of the human polyomaviruses. J. Gen. Virol. 84:14991504.
82. Tantisiriwat, W.,, P. Tebas,, D. B. Clifford,, W. G. Powderly, and, C. J. Fichtenbaum. 1999. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin. Infect. Dis. 28:11521154.
83. Taoufik, Y.,, J. F. Delfraissy, and, J. Gasnault. 2000. Highly active antiretroviral therapy does not improve survival of patients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagnosis. AIDS 14:758759.
84. Tassie, J. M.,, J. Gasnault,, M. Bentata,, J. Deloumeaux,, F. Boué,, E. Billaud,, D. Costagliola,and Clinical Epidemiology Group from the French Hospital Database on HIV. 1999. Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. AIDS 13:18811887.
85. Telenti, A.,, W. F. Marshall,, A. J. Aksamit,, J. D. Smilack, and, T. F. Smith. 1992. Detection of JC virus by polymerase chain reaction in cerebrospinal fluid from two patients with progressive multifocal leukoencephalopathy. Eur. J. Clin. Microbiol. Infect. Dis. 11:253254.
86. Ueki, K.,, E. P. Richardson,, J. W. Henson, and, D. N. Louis. 1994. In situ polymerase chain reaction demonstration of JC virus in progressive multifocal leukoencephalopathy, including an index case. Ann. Neurol. 36:670673.
87. Vago, L.,, P. Cinque,, E. Sala,, M. Nebuloni,, R. Caldarelli,, S. Racca,, P. Ferrante,, G. R. Trabattoni, and, G. Costanzi. 1996. JCV-DNA and BKV-DNA in the CNS tissue and CSF of AIDS patients and normal subjects. Study of 41 cases and review of the literature. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 12:139146.
88. Van Assche, G.,, M. Van Ranst,, R. Sciot,, B. Dubois,, S. Vermeire,, M. Noman,, J. Verbeeck,, K. Geboes,, W. Robberecht, and, P. Rutgeerts. 2005. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn’s disease. N. Engl. J. Med. 353:362368.
89. Vendrely, A.,, B. Bienvenu,, J. Gasnault,, J. B. Thiebault,, D. Salmon, and, F. Gray. 2005. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol. 109:449455.
90. Weber, F.,, C. Goldmann,, M. Krämer,, F. J. Kaup,, M. Pickhardt,, P. Young,, H. Petry,, T. Weber, and, W. Lüke. 2001a. Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann. Neurol. 49:636642.
91. Weber, T.,, R. Beck,, E. Stark,, J. Gerhards,, K. Korn,, J. Haas,, W. Lüer, and, G. Jahn. 1994a. Comparative analysis of intrathecal antibody synthesis and DNA amplification for the diagnosis of cytomegalovirus infection of the central nervous system in AIDS patients. J. Neurol. 241:407414.
92. Weber, T.,, C. Trebst,, S. Frye,, P. Cinque,, L. Vago,, C. J. M. Sindic,, W. J. Schulz-Schaeffer,, H. A. Kretzschmar,, W. Enzensberger,, G. Hunsmann, and, W. Lüke. 1997. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 176:250254.
93. Weber, T.,, R. W. Turner,, S. Frye,, W. Lüke,, H. A. Kretzschmar,, W. Lüer, and, G. Hunsmann. 1994b. Progressive multifocal leukoencephalopathy diagnosed by amplification of JC virus-specific DNA from cerebrospinal fluid. AIDS 8:4957.
94. Weber, T.,, R. W. Turner,, S. Frye,, B. Ruf,, J. Haas,, E. Schielke,, H. D. Pohle,, W. Lüke,, W. Lüer,, K. Felgenhauer, and, G. Hunsmann. 1994c. Specific diagnosis of progressive multifocal leukoencephalopathy by polymerase chain reaction. J. Infect. Dis. 169:11381141.
95. Weber, T.,, F. Weber,, H. Petry, and, W. Luke. 2001b. Immune response in progressive multifocal leukoencephalopathy: an overview. J. Neurovirol. 7:311317.
96. Weiner, S. M.,, J. Laubenberger,, K. Müller,, J. Schneider, and, W. Kreisel. 2000. Fatal course of HIV-associated progressive multifocal leukoencephalopathy despite successful highly active antiretroviral therapy. J. Infect. 40:100102.
97. Wheeler, A. L.,, C. L. Truwit,, B. K. Kleinschmidt-DeMasters,, W. R. Byrne, and, R. N. Hannon. 1993. Progressive multifocal leukoencephalopathy: contrast enhancement on CT scans and MR images. AJR Am. J. Roentgenol. 161:10491051.
98. Woo, H. H.,, A. R. Rezai,, E. A. Knopp,, H. L. Weiner,, D. C. Miller, and, P. J. Kelly. 1996. Contrast-enhancing progressive multifocal leukoencephalopathy: radiological and pathological correlations: case report. Neurosurgery 39:10311035.
99. Yiannoutsos, C. T.,, E. O. Major,, B. Curfman,, P. N. Jensen,, M. Gravell,, J. Hou,, D. B. Clifford, and, C. D. Hall. 1999. Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann. Neurol. 45:816820.
100. Yousry, T. A.,, E. O. Major,, C. Ryschkewitsch,, G. Fahle,, S. Fischer,, J. Hou,, B. Curfman,, K. Miszkiel,, N. Mueller-Lenke,, E. Sanchez,, F. Barkhof,, E. W. Radue,, H. R. Jäger, and, D. B. Clifford. 2006. Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N. Engl. J. Med. 354:924933.
101. Zunt, J. R.,, R. K. Tu,, D. M. Anderson,, M. C. Copass, and, C. M. Marra. 1997. Progressive multifocal leukoencephalopathy presenting as human immunodeficiency virus type 1 (HIV)-associated dementia. Neurology 49:263265.

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error